E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 1, p. 40, doi. 10.1038/sj.cgt.7701099
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2008 AND VI 15 AND IP 1
Results: 6
1
2
Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 1, p. 9, doi. 10.1038/sj.cgt.7701093
- By:
- Publication type:
- Article
3
Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 1, p. 29, doi. 10.1038/sj.cgt.7701094
- By:
- Publication type:
- Article
4
MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin–proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 1, p. 1, doi. 10.1038/sj.cgt.7701095
- By:
- Publication type:
- Article
5
Modified vaccinia virus Ankara as a vector for suicide gene therapy.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 1, p. 18, doi. 10.1038/sj.cgt.7701098
- By:
- Publication type:
- Article
6
Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 1, p. 51, doi. 10.1038/sj.cgt.7701104
- By:
- Publication type:
- Article